Medifast, Inc.

Equities

MED

US58470H1014

Food Processing

Real-time Estimate Cboe BZX 09:50:37 2024-03-28 am EDT 5-day change 1st Jan Change
37.9 USD +1.00% Intraday chart for Medifast, Inc. +6.34% -43.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Medifast, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Medifast, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Earnings Flash (MED) MEDIFAST Posts Q4 EPS $1.09, vs. Street Est of $0.96 MT
Earnings Flash (MED) MEDIFAST Reports Q4 Revenue $191M, vs. Street Est of $184.2M MT
Medifast Provides Earnings Guidance for the First Quarter of 2024 CI
Medifast, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Health Care Climbs After Fed Policy Move -- Health Care Roundup DJ
Medifast, LifeMD Collaborate to Offer Weight Management Solution; Medifast Scraps Quarterly Dividend MT
Transcript : LifeMD, Inc., Medifast, Inc. - Special Call
Medifast's Board of Directors Elect to Discontinue the Company's Quarterly Cash Dividend CI
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, Inc CI
Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013. CI
Medifast, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Medifast, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Earnings Flash (MED) MEDIFAST Posts Q3 Revenue $235.9M, vs. Street Est of $232.1M MT
Medifast, Inc. Provides Earnings Guidance for the Full Year 2023 CI
Stephens Initiates Medifast With Equalweight Rating, Price Target is $82 MT
Medifast Unveils Supplements for Muscle Health MT
Medifast, Inc. Announces Optavia Active Now Available CI
Medifast Keeps Quarterly Dividend at $1.65 a Share, Payable Nov. 7 to Shareholders of Record Sept. 19 MT
Medifast, Inc. Declares Quarterly Cash Dividend, Payable on November 7, 2023 CI
Insider Sell: Medifast MT
Medifast Q2 Net Income, Revenue Fall; Q3 Outlook Set -- Shares Jump After-Hours MT
Tranche Update on Medifast, Inc.'s Equity Buyback Plan announced on December 9, 2013. CI
Transcript : Medifast, Inc., Q2 2023 Earnings Call, Aug 07, 2023
Chart Medifast, Inc.
More charts
Medifast, Inc. (Medifast) is a health and wellness company. The Company sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast's product line includes more than 65 consumable options, including, but not limited to, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. OPTAVIA coaches also counsel their customers on how to develop healthy habits, such as preparing lean and green meals and choosing healthy snacks. Medifast nutritional products are formulated with high-quality ingredients. Medifast's wholly owned subsidiaries include Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, and OPTAVIA (Singapore) PTE. LTD
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
37.53 USD
Average target price
37.5 USD
Spread / Average Target
-0.08%
Consensus
  1. Stock
  2. Equities
  3. Stock Medifast, Inc. - Nyse
  4. News Medifast, Inc.
  5. Insider Trends: Medifast Insider Extends 90-Day Selling Trend